Can a medical glue stop repeat brain bleeds? new study seeks answers.

NCT ID NCT07258069

Recruiting now Disease control Sponsor: Aesculap AG Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether a substance called Histoacryl can prevent chronic subdural hematoma (a type of brain bleed) from coming back or getting worse. About 178 adults with this condition will receive a procedure to block the middle meningeal artery using Histoacryl. Researchers will track how many people need another surgery or show signs of the bleed returning over 6 months.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SUBDURAL HEMATOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Hematoma, Subdural Hematoma, Subdural, Chronic

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SUBDURAL HEMATOMA SUBDURAL HEMATOMA, CHRONIC

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

Kobe City Medical Center General Hospital
NOT_YET_RECRUITING

Kobe, Chuo-ku, 〒650-0047, Japan
Kokura Memorial Hospital
NOT_YET_RECRUITING

Fukuoka, Kitakyushu-city, 〒802-8555, Japan
Kyoto University Hospital
NOT_YET_RECRUITING

Kyoto, Sakyo-ku, 〒606-8507, Japan
National Cerebral and Cardiovascular Center
NOT_YET_RECRUITING

Osaka, Suita, 〒564-8565, Japan
National Hospital Organization Osaka National Hospital
NOT_YET_RECRUITING

Osaka-Fu, Osaka-shi, 〒540-0006, Japan
Ohara HealthCare Foundation Kurashiki Central Hospital
NOT_YET_RECRUITING

Okayama, Kurashiki, 〒710-8602, Japan
Shimizu Hospital
RECRUITING

Kyoto, Nishikyo-ku, 〒615-8237, Japan

More trials for these conditions

Other studies related to the condition(s) this trial covers.